ISEC Healthcare (40T) AGM 2026 presentation summary

Business overview

• Operates 12 eye care centres in Malaysia, 1 in Singapore, and 1 in Myanmar, with further expansion planned in Seremban and Batu Pahat by end 2026.

• Business model aligns specialist doctors' interests with shareholders and features strong cash flow and high-quality services.

• Well positioned to capture growing demand for private eye care in Asia-Pacific, leveraging state-of-the-art technology.

Financial highlights

• Revenue grew 7% year-over-year to S$79.2 million in FY2025, continuing a five-year upward trend.

• Net profit increased 5% to S$13.4 million, with a net profit margin of 16.9%.

• Earnings per share rose 4% to 2.32 Singapore cents.

• Net asset value attributable to owners increased 13% to S$101.8 million.

• Dividend payout reduced to S$3.3 million (0.58 Singapore cents per share), reflecting cash conservation for capital projects.

Revenue breakdown

• Specialised health services contributed 95% of total revenue, with a 7% increase in FY2025.

• Malaysia accounted for 80% of revenue, Singapore 16%, and Myanmar 4%; all regions saw revenue growth.